During the past decade, Mater Adult Hospital conducted 79 clinical trials. In the 10-year time frame, 79 clinical trials started and 40 clinical trials were completed, i.e. on average, 50.6% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 31 clinical trials were completed. i.e. 110.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mater Adult Hospital" #1 sponsor was "Celgene" with 15 trials, followed by "Vertex Pharmaceuticals Incorporated" with 11 trials sponsored, "Janssen Research & Development, LLC" with 8 trials sponsored, "Eli Lilly and Company" with 7 trials sponsored and "Hoffmann-La Roche" with 7 trials sponsored. Other sponsors include 61 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mater Adult Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 3 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 2 trials as a collaborator, "Basilea Pharmaceutica International Ltd" with 2 trials as a collaborator, "Baxter Healthcare Corporation" with 2 trials as a collaborator and "Cancer Council New South Wales" with 2 trials as a collaborator. Other collaborators include 63 different institutions and companies that were collaborators in the rest 71 trials.

According to Clinical.Site data, the most researched conditions in "Mater Adult Hospital" are "Cystic Fibrosis" (16 trials), "Ulcerative Colitis" (11 trials), "Crohn Disease" (8 trials), "Crohn's Disease" (7 trials) and "Ovarian Cancer" (6 trials). Many other conditions were trialed in "Mater Adult Hospital" in a lesser frequency.

Most popular intervention types in "Mater Adult Hospital" are "Drug" (104 trials), "Other" (19 trials), "Biological" (7 trials), "Procedure" (7 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (43 trials), "IVA" (10 trials), "ELX/TEZ/IVA" (7 trials), "Carboplatin" (4 trials) and "GED-0301" (4 trials). Other intervention names were less common.

The vast majority of trials in "Mater Adult Hospital" are 100 trials for "All" genders, 13 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Mater Adult Hospital". undefined are not yet recruiting, 19 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 62 completed trials in Mater Adult Hospital, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Mater Adult Hospital, 11 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 74 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".